Gujarat Terce Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve The Unaudited Standalone Financial Results Of The Company For The Second Quarter And Half Year Ended 30 September 2026.

29 October 2026 BSE Limited (Security Code: 524314) Phiroze Jeejeeboy Towers, Dalal Street, Fort, Mumbai- 400 001. Dear Sir/Madam, Subject: Intimation of Board Meeting of Gujarat Terce Laboratories Limited In compliance with Regulation 29 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of Gujarat Terce Laboratories Limited (“the Company”) is scheduled to be held on Thursday, 5 November 2026 to inter alia to consider and approve the Unaudited Standalone Financial Results of the Company for the second quarter and half year ended 30 September 2026, which shall be subject to limited review by the Statutory Auditor of the Company In terms of the Company’s Code of Conduct for Prevention of Insider Trading in Securities of Gujarat Terce Laboratories Limited, the Trading Window of the Company has been closed from Thursday, 1 October 2026 till the end of forty-eight hours after the declaration of Unaudited Financial Results of the Company for the Second quarter and half year ending on 30 September 2026 (i.e. till 7 November 2026). This intimation is also being uploaded on the Company’s website and can be accessed at the weblink: https://www.gujaratterce.in/financial-results/ . Kindly take the above on record. Thanking you For Gujarat Terce Laboratories Limited Ashka Solanki Company Secretary